ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 29 filers reported holding ORAMED PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $2,000 | – | 700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 781,292 | $2,039,172 | 1.87% |
| GSA CAPITAL PARTNERS LLP | 88,923 | $232 | 0.02% |
| Glass Jacobson Investment Advisors llc | 12,255 | $31,986 | 0.02% |
| Rathbones Group PLC | 289,803 | $756,386 | 0.01% |
| N.E.W. Advisory Services LLC | 12,960 | $33,826 | 0.01% |
| Virtu Financial LLC | 17,388 | $45 | 0.00% |
| BOURGEON CAPITAL MANAGEMENT LLC | 5,627 | $14,687 | 0.00% |
| ALGERT GLOBAL LLC | 14,680 | $38 | 0.00% |
| Close Asset Management Ltd | 11,400 | $30 | 0.00% |
| Altshuler Shaham Ltd | 12,847 | $33,408 | 0.00% |